YYYinfeng Yang

Yinfeng Yang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yinfeng Yang has a total of 13 co-authors. Here are the top co-authors by number of shared publications:

  • Bohui Li

    Center for Bioinformatics, College of Life Science, Northwest A&F University, Yangling, Shaanxi 712100, China

    1 shared publication
  • Chao Huang

    Key Laboratory of Resource Biology and Biotechnology in Western China (Northwest University), Ministry of Education, School of Life Sciences, Northwest University, Xi'an, China; Lab of Systems Pharmacology, Center of Bioinformatics, College of Life Science, Northwest A&F University, Yangling, China

    1 shared publication
  • Jinan Wang

    Center for Bioinformatics, College of Life Science, Northwest A&F University, Yangling, Shaanxi 712100, China

    1 shared publication
  • Jinlong Ru

    Prevention of Microbial Diseases, TUM School of Life Sciences; Central Institute of Infection Prevention (ZIP), Technical University of Munich, Freising, Germany

    1 shared publication
  • Ling Yang

    Shanghai Frontiers Science Center of TCM Chemical Biology, , , Shanghai, China

    1 shared publication
  • Peng Li

    College of Basic Sciences, Shanxi Agricultural University, 1 Mingxian South Road, Taigu District, Jinzhong, 030801, China

    1 shared publication

Latest Publications

  • Top Cited Papers
    Open Access

    TCMSP: a database of systems pharmacology for drug discovery from herbal medicines

    by Jinlong Ru, Peng Li, Jinan Wang, Wei Zhou, Bohui Li, Chao Huang, Pidong Li, Zihu Guo, Weiyang Tao, Yinfeng Yang, et al.

    Background: Modern medicine often clashes with traditional medicine such as Chinese herbal medicine because of the little understanding of the underlying mechanisms of action of the herbs. In an effort to promote integration of both sides and to accelerate the drug discovery from herbal medicines, an efficient systems pharmacology platform that represents ideal information convergence of pharmacochemistry, ADME properties, drug-likeness, drug targets, associated diseases and interaction networks, are urgently needed. Description: The traditional Chinese medicine systems pharmacology database and analysis platform (TCMSP) was built based on the framework of systems pharmacology for herbal medicines. It consists of all the 499 Chinese herbs registered in the Chinese pharmacopoeia with 29,384 ingredients, 3,311 targets and 837 associated diseases. Twelve important ADME-related properties like human oral bioavailability, half-life, drug-likeness, Caco-2 permeability, blood-brain barrier and Lipinski’s rule of five are provided for drug screening and evaluation. TCMSP also provides drug targets and diseases of each active compound, which can automatically establish the compound-target and target-disease networks that let users view and analyze the drug action mechanisms. It is designed to fuel the development of herbal medicines and to promote integration of modern medicine and traditional medicine for drug discovery and development. Conclusions: The particular strengths of TCMSP are the composition of the large number of herbal entries, and the ability to identify drug-target networks and drug-disease networks, which will help revealing the mechanisms of action of Chinese herbs, uncovering the nature of TCM theory and developing new herb-oriented drugs. TCMSP is freely available at http://sm.nwsuaf.edu.cn/lsp/tcmsp.php.